首页 | 本学科首页   官方微博 | 高级检索  
检索        

左氧氟沙星三联疗法根除幽门螺杆菌感染106例
引用本文:陈炎,陈亚蓓,陶荣芳.左氧氟沙星三联疗法根除幽门螺杆菌感染106例[J].中国新药与临床杂志,2002,21(7):437-439.
作者姓名:陈炎  陈亚蓓  陶荣芳
作者单位:1. 明光市中医院,安徽,明光,239400
2. 明光市医院,安徽,明光,239400
摘    要:目的 :观察左氧氟沙星短程三联疗法根除幽门螺杆菌 (Hp)感染的疗效。方法 :1 0 6例Hp阳性病人 A组。男性 66例 ,女性 40例 ;年龄 5 9a±s1 1a;慢性浅表性胃炎 (CSG) 5 8例 ,消化性溃疡(PU) 48例]予胶态次枸椽酸铋 2 2 0mg,左氧氟沙星2 0 0mg及呋喃唑酮 2 0 0mg ,po,bid。另 1 1 0例Hp阳性病人 (B组。男性 69例 ,女性 41例 ;年龄5 7a± 9a;CSG 63例 ,PU 47例 )予奥美拉唑 2 0mg ,克拉霉素 5 0 0mg及阿莫西林 1 0 0 0mg,po,bid。疗程均为 1wk。疗程结束后 4wk及 1 2mo复查胃镜及Hp。结果 :A ,B 2组停药 1 2mo后Hp根除率各为 82 .1 % ,83 .6% ,P >0 .0 5。均无严重不良反应。每例清除Hp药费各为 1 2 3 .5元 ,5 5 5 .8元。结论 :2组Hp根除率相近 ,但A组费用较低

关 键 词:幽门螺杆菌  左氧氟沙星  胶态次枸椽酸铋  呋喃唑酮  奥美拉唑  克拉霉素  阿莫西林
文章编号:1007-7669(2002)07-0437-03

Levofloxacin triple therapy in eradication of Helicobacter pylori infection in one hundred and six patients
CHEN Yan ,CHEN Ya bei ,TAO Rong fang.Levofloxacin triple therapy in eradication of Helicobacter pylori infection in one hundred and six patients[J].Chinese Journal of New Drugs and Clinical Remedies,2002,21(7):437-439.
Authors:CHEN Yan  CHEN Ya bei  TAO Rong fang
Institution:CHEN Yan 1,CHEN Ya bei 1,TAO Rong fang 2
Abstract:AIM: To observe the efficacy of levofloxacin triple therapy in eradication of Helicobacter pylori (Hp ) infection METHODS: One hundred and six patients with Hp infection Group A, M 66, F 40; age 59 a± s 11 a; chronic superficial gastritis (CSG) 58, peptic ulcer (PU) 48] were treated with colloidal bismuth subcitrate (CBS) 220 mg, levofloxacin 200 mg and furazolidone 200 mg, po, bid for 1 wk. The another one hundred and ten patients (Group B, M 69, F 41; age 57 a±9 a; CSG 63, PU 47) were treated with omeprazole 20 mg, clarithromycin 500 mg and amoxicillin 1 000 mg, po, bid for 1 wk. Four weeks and twelve months after anti Hp therapy endoscopy and tests for Hp were repeated. RESULTS: The eradication rates of Hp in group A and group B were 82.1 % and 83.6 % respectively ( P> 0.05). The cost of anti Hp therapy of every patient was 123.5 Yuans (RMB) in group A and 555.8 Yuans (RMB) in group B. CONCLUSION: The eradication rates of Hp in both groups are similar, without severe adverse reaction. But group A has a lower cost than group B.
Keywords:Helicobacter pyroli  levofloxacin  colloidal bismuth subcitrate  furazolidone  omeprazole  clarithromycin  amoxicillin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号